| ImExHS Limited (IME) ORDINARY FULLY PAID |
Health Care |
$22 |
IMEXHS Reports FY25 Results
|
27 Feb 2026 10:48AM |
$0.410 |
$0.400 |
fallen by
2.44%
|
|
IME - Price-sensitive ASX Announcement
Full Release
Key Points
- IMEXHS Limited reported FY25 revenue of $29.0 million.
- Underlying EBITDA rose to $1.6 million from $0.5 million.
- Annualised Recurring Revenue (ARR) reached $34.8 million.
- Processed 8.2 million studies with 99.8% platform uptime.
- Software ARR grew to $11.8 million, a 19% increase.
- Strategic enterprise wins and expanded partner programs.
- Improved working capital, reduced debt, and increased cash.
- IMEXHS expects to exceed FY25 financial performance in FY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Advance ZincTek Limited (ANO) ORDINARY FULLY PAID |
Materials |
$61 |
Appendix 4D
|
27 Feb 2026 10:48AM |
$0.975 |
$0.975 |
fallen by
0%
|
|
ANO - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from ordinary activities increased by 16.5% to $6,662,000.
- Net profit attributable to members rose by 21.38% to $1,158,000.
- Net tangible assets per share increased to 44.49 cents.
- Basic earnings per share increased to 1.84 cents.
- No interim dividend will be paid for this period.
- No changes in control over subsidiaries.
- No control gained or lost over entities during this period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Enlitic Inc (ENL) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$6 |
Corporate Governance Statement & Appendix 4G
|
27 Feb 2026 10:47AM |
$0.009 |
$0.007 |
fallen by
22.22%
|
|
| ImExHS Limited (IME) ORDINARY FULLY PAID |
Health Care |
$22 |
Appendix 4E & Annual Report 2025
|
27 Feb 2026 10:47AM |
$0.410 |
$0.400 |
fallen by
2.44%
|
|
IME - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss increased by 11% to A$4.94 million.
- Revenue from ordinary activities decreased significantly.
- Successful Phase III clinical trial of Felix™ System.
- CE Mark application submitted for European market entry.
- Strategic focus on commercialisation and international expansion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ovanti Limited (OVT) ORDINARY FULLY PAID |
Communication Services |
$9 |
Notice of Proposed Share Consolidation
|
27 Feb 2026 10:46AM |
$0.001 |
$0.001 |
fallen by
0%
|
|
OVT - Price-sensitive ASX Announcement
Full Release
Key Points
- Consolidation ratio 20:1
- Requires shareholder approval at EGM on 30 March 2026
- Aimed at improving capital structure
- Options to be consolidated with adjusted exercise prices
- Fractional entitlements to be rounded up
- Indicative timetable provided
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Enlitic Inc (ENL) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$6 |
Appendix 4E & 2025 Annual Report
|
27 Feb 2026 10:46AM |
$0.009 |
$0.007 |
fallen by
22.22%
|
|
ENL - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased to US$3.8 million for 2025.
- Loss after tax was US$13.4 million.
- Laitek acquisition expanded revenue base.
- Strategic partnership with GE Healthcare.
- Focus on AI-driven data governance and usability.
- Capital raised to support growth and commercialization.
- Audited financial report with unmodified opinion.
- No dividends declared for the current period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Morphic Ethical Equities Fund Limited (MEC) ORDINARY FULLY PAID |
Financials |
$37 |
NTA at 13.02.2026 Pre-tax 1.3684 and Post-tax 1.3091
|
27 Feb 2026 10:46AM |
$1.195 |
$1.180 |
fallen by
1.26%
|
|
| Memphasys Limited (MEM) ORDINARY FULLY PAID |
Health Care |
$14 |
Appendix 4D - Half-year Financial Report - 31 December 2025
|
27 Feb 2026 10:45AM |
$0.006 |
$0.005 |
fallen by
16.67%
|
|
MEM - Price-sensitive ASX Announcement
Full Release
Key Points
- Memphasys Limited recorded a net loss after tax of $2,338,819 for the half-year ended 31 December 2025.
- Operating revenue of $12,406 was recognized during the period due to the commencement of commercial invoicing following regulatory approvals.
- Orders from Europe and the MENA region amounted to $94,008, with additional orders from Japan valued at $17,558.
- No impairment of intangible assets was recognized, compared to an impairment of $896,400 in the prior period.
- Employee benefits expenses increased due to termination payments and restructuring costs.
- Compliance, audit, tax, and legal expenses increased significantly.
- Research and development expenses decreased as the company shifted focus to commercial execution.
- The company completed capital raising activities generating $1.9 million in gross proceeds.
- The Felix™ System achieved global regulatory milestones, including UK and TGA approvals.
- The company executed a five-year supply agreement in Europe worth approximately A$925,000.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rectifier Technologies Ltd (RFT) ORDINARY FULLY PAID |
Industrials |
$4 |
Half Yearly Report and Accounts
|
27 Feb 2026 10:44AM |
$0.004 |
$0.003 |
fallen by
25%
|
|
RFT - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue decreased by 61.4% to $3,889,883.
- Loss after tax was $2,351,869, down from a profit of $882,868.
- Significant revenue drop in the European market.
- No dividends declared during the period.
- Total assets remained at approximately $27.66 million.
- Auditors issued an unqualified conclusion for the financial statements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ovanti Limited (OVT) ORDINARY FULLY PAID |
Communication Services |
$9 |
Notice of Extraordinary General Meeting/Proxy Form
|
27 Feb 2026 10:43AM |
$0.001 |
$0.001 |
fallen by
0%
|
|
OVT - Price-sensitive ASX Announcement
Full Release
Key Points
- Notice of Extraordinary General Meeting for Ovanti Limited
- Meeting scheduled for 30 March 2026 in Sydney, NSW
- Instructions for lodging proxy forms online, by mail, in person, or via email
- Resolutions include ratification of prior issues, share consolidation, and future share issuance
- Shareholders must provide voting directions or authorize the Chair to vote
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Future Generation Global Limited (FGG) ORDINARY FULLY PAID |
Financials |
$636 |
2025 Full Year Results, strong TSR and increased FF divs
|
27 Feb 2026 10:41AM |
$1.650 |
$1.585 |
fallen by
3.94%
|
|
FGG - Price-sensitive ASX Announcement
Full Release
Key Points
- Full-year results show a 16.2% total shareholder return for FY2025.
- Declared fully franked full-year dividend of 8.0 cents per share.
- Special fully franked dividend of 3.0 cents per share announced.
- Investment portfolio managed by 16 leading pro bono fund managers.
- 3-year investment portfolio performance was 18.1% per annum.
- Operating profit before tax for FY2025 was $67.9 million.
- Portfolio is diversified across sectors and regions, underweight in mega-cap tech.
- Total of $50.5 million donated to mental health initiatives since inception.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Staude Capital Global Value Fund Limited (GVF) ORDINARY FULLY PAID |
Financials |
$279 |
GVF delivers another half year of healthy returns
|
27 Feb 2026 10:39AM |
$1.365 |
$1.380 |
risen by
1.10%
|
|
GVF - Price-sensitive ASX Announcement
Full Release
Key Points
- Operating profit before tax of $11.5M.
- Adjusted pre-tax NTA increased by 4.4%.
- Discount capture strategy added 3% to returns.
- Fully franked dividend of 3.3 cents per share declared.
- Total grossed-up dividends since IPO match original share price.
- Dividend reinvestment plan provides lowest reinvestment price.
- FY2026 full year dividend expected to match interim dividend.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Staude Capital Global Value Fund Limited (GVF) ORDINARY FULLY PAID |
Financials |
$279 |
Dividend/Distribution - GVF
|
27 Feb 2026 10:38AM |
$1.365 |
$1.380 |
risen by
1.10%
|
|
| WAM Research Limited (WAX) ORDINARY FULLY PAID |
Financials |
$244 |
WAX maintains interim dividend, 2026 Half Year Results
|
27 Feb 2026 10:38AM |
$1.210 |
$1.170 |
fallen by
3.31%
|
|
WAX - Price-sensitive ASX Announcement
Full Release
Key Points
- Maintenance of interim dividend of 5.0 cents per share, partially franked at 60%.
- Investment portfolio decreased by 1.8% for the six months ending 31 December 2025.
- Outperformed S&P/ASX All Ordinaries Accumulation Index over the three and five-year periods.
- Annualised interim dividend yield of 8.2% and grossed-up yield of 10.3%.
- The company's share price is trading 25.2% above its NTA.
- Reported operating loss for the period but remains confident in future strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Staude Capital Global Value Fund Limited (GVF) ORDINARY FULLY PAID |
Financials |
$279 |
Appendix 4D & Half Year Results - 31 December 2025
|
27 Feb 2026 10:37AM |
$1.365 |
$1.380 |
risen by
1.10%
|
|
GVF - Price-sensitive ASX Announcement
Full Release
Key Points
- 4.4% increase in adjusted pre-tax net tangible assets.
- Net profit after tax of $8.7 million.
- Fully-franked final dividend of 3.30 cents per share.
- Share purchase plan raised $18.1 million.
- Investment focus on global financial markets with a discount strategy.
- Performance contributors: HarbourVest Global Private Equity and Amedeo Air Four Plus.
- Exited position in Empiric Student Property.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bathurst Resources Limited (BRL) ORDINARY FULLY PAID |
Materials |
$144 |
Half Year Results Webcast Presentation
|
27 Feb 2026 10:37AM |
$0.670 |
$0.600 |
fallen by
10.45%
|
|
| iTech Minerals Ltd (ITM) ORDINARY FULLY PAID |
Materials |
$10 |
iTech Minerals Half-year Report
|
27 Feb 2026 10:37AM |
$0.040 |
$0.043 |
risen by
7.50%
|
|
| Future Generation Australia Limited (FGX) ORDINARY FULLY PAID |
Financials |
$553 |
Strong invest. port. outperformance drives increased FF div
|
27 Feb 2026 10:34AM |
$1.420 |
$1.345 |
fallen by
5.28%
|
|
FGX - Price-sensitive ASX Announcement
Full Release
Key Points
- Investment portfolio outperformed the market by 3.5%
- Declared final dividend of 3.6 cents per share, total dividend 7.2 cents per share
- Fully franked dividend yield of 5.1% and grossed-up yield of 7.3%
- Increased dividends every year for eleven years
- Donation of $5.7 million to social impact partners
- Diversified portfolio managed by leading fund managers
- Company's financial year is 1 January to 31 December
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Anagenics Limited (AN1) ORDINARY FULLY PAID |
Consumer Staple |
$7 |
Change of Director's Interest Notice
|
27 Feb 2026 10:29AM |
$0.007 |
$0.007 |
fallen by
0%
|
|
| International Equities Corporation Limited (IEQ) ORDINARY FULLY PAID |
Real Estate |
$5 |
Half Yearly Report and Accounts
|
27 Feb 2026 10:27AM |
$0.040 |
$0.040 |
fallen by
0%
|
|
IEQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from continuing operations increased by 6.83% to $673,000 compared to December 2024.
- Revenue from discontinued operations decreased by 27.52% to $453,000 compared to December 2024.
- Net loss for the period decreased by 40.10% to $251,000 compared to December 2024.
- No dividends were declared for the period.
- Focus remains on property development, management, and tourism as core business areas.
- The company's activities have scaled down, with a focus on maintaining operations at the only remaining hotel property in Melbourne.
- Financial performance was adversely affected by high costs, inflation, and interest rates.
- Consolidated revenues for the half year ended 31 December 2025 were $1.126 million.
- The total comprehensive loss for the period was $251,000.
- The company aims to remain cash neutral and service debt while reorganizing its principal activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WAM Alternative Assets Limited (WMA) ORDINARY FULLY PAID |
Financials |
$190 |
Appendix 4D and Financial Report
|
27 Feb 2026 10:24AM |
$1.020 |
$0.965 |
fallen by
5.39%
|
|
WMA - Price-sensitive ASX Announcement
Full Release
Key Points
- Total assets were $270.2 million as of December 31, 2025.
- Net profit after tax was $6.47 million.
- Implementation of a new treasury solution by Fortlake Asset Management via the Fortlake Real-Income Fund.
- Financial assets measured at fair value were $268.1 million.
- Significant investments made in unlisted funds such as private equity, real estate, and infrastructure.
- Net cash used in operating activities was $34.07 million.
- Dividends paid amounted to $5.897 million.
- Uncalled capital commitments were $36.43 million as of December 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Light & Wonder Inc. (LNW) CHESS DEPOSITARY INTERESTS 1:1 |
Consumer Discretionary |
$10,144 |
Application for quotation of securities - LNW
|
27 Feb 2026 10:23AM |
$136.990 |
$126.350 |
fallen by
7.77%
|
|
| Findi Limited (FND) ORDINARY FULLY PAID |
Financials |
$67 |
Supplementary Prospectus
|
27 Feb 2026 10:23AM |
$0.800 |
$1.050 |
risen by
31.25%
|
|
| Austin Metals Limited (AYT) ORDINARY FULLY PAID |
Materials |
$9 |
Notification regarding unquoted securities - AYT
|
27 Feb 2026 10:20AM |
$0.004 |
$0.004 |
fallen by
0%
|
|
| Future Generation Global Limited (FGG) ORDINARY FULLY PAID |
Financials |
$636 |
Appendix 4E and Annual Report
|
27 Feb 2026 10:19AM |
$1.640 |
$1.585 |
fallen by
3.35%
|
|
FGG - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from ordinary activities decreased by 48.6% to $75,799,000.
- Net profit after tax fell by 50.8% to $47,998,000.
- Declared a final dividend of 4.0 cents and a special dividend of 3.0 cents, both fully franked.
- 8.9 years of dividend coverage based on profits reserve.
- Investment portfolio performance increased by 11.5% in 2025.
- Social investments totaled $50.5 million since inception.
- Appointed Lee Hopperton as Chief Investment Officer in February 2025.
- Caroline Gurney stepped down as CEO in February 2026.
- Investment strategy underweights mega-cap tech stocks, focusing on diversified exposure.
- FGG operates pro bono partnerships to support mental health initiatives among youth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
